uk ru en
LIFE SCIENCES LAWYERS | UKRAINE & CIS
Menu

LEGAL ALLIANCE, founded in 1995, is today one of the leading Ukrainian law firms specializing in legal support to pharmaceutical companies doing business in Ukraine and CIS countries.

OUR CLIENTS represent the following industries: pharmaceuticals, medical devices, consumer goods, medicine, cosmetics, para-pharmaceuticals, chemistry, biotechnology, agriculture and food products.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen Legal Alliance as their legal advisor.

Legal Alliance Is a Legal Adviser of Safemed Project

In April results of tender for provision of legal support to the Project on Introduction of the National List of Essential Medicines and Creation of the Agency of Medical Technologies Assessment (MTA) in Ukraine, carried by Management Sciences for Health within the framework of USAID / SAFEMed, became known.

Upon the tender, team of Legal Alliance Company has been selected as a legal adviser of SAFEMed project on technical aid to the Government of Ukraine, the Ministry of Health and the Expert Committee for Selection and Use of Essential Medicines for increasing transparency of pharmaceutical system of Ukraine, consultations on approval of the National Medicines Policy, development of regulatory basis for creation and operation of the MTA Agency, legal support to the processes related to functioning of the National List of Essential Medicines and transition to the electronic document flow model.

“A lot of interesting and creative work on which development and effectiveness of the pharmaceutical system and improvement of access to medicines depend is waiting for us ahead”, comments Dmytro Aleshko, partner at Legal Alliance Company.

Management Sciences for Health is an international non-profitable organization which has been cooperating with governments, civil society, private sector and thousands of medical professionals at the local level for more than 45 years in order to strengthen the healthcare system, expand access to medicines and services and improve quality of medical care.

2889

If you find out a mistake, please, mark it and select Ctrl+Enter to inform us